Drug Information Association Logo

Building an MSL Team

Track:
Medical Science Liasons Track

Day & Time:
March 12, 1:00PM - 2:30PM

Room Number:
Regency Hall 1 & 2

Type:
Session

Title:
Building an MSL Team

Chair(s):
Edmund J Cunningham, PharmD
Director, Speciality Care MSLs Medical Affairs
Eisai Inc., United States

Description:
As the industry evolves, many organizations’ needs have turned to an increased focus on supporting the clinical development of compounds and launch products. Medical Science Liaisons (MSLs) serve a critical role in this paradigm as scientific experts in the field, communicating the science behind the company’s products and developing relationships with key opinion leaders (KOLs) in the therapeutic area. Many organizations recognize the need for MSL capabilities and the importance of either establishing new MSL teams or increasing their MSL resources to meet their needs. This session discusses concepts involved in building effective MSL teams, including identifying the capabilities that are needed, determining the appropriate number of MSL team members, developing the necessary infrastructure to support MSL effectiveness in alignment with an organization’s needs, and communicating the value of the MSL team to management and other internal customers.

Learning Objective(s):
Discuss the strategic considerations associated with building an MSL organization, including the strategic scientific focus and anticipated MSL customer base
Identify methods of determining appropriate MSL resourcing based on staffing models, as well as the technical needs and scope of MSL responsibilities
Describe the approaches and considerations involved with effectively recruiting an MSL team

Presentation(s) & Speaker(s):
Building an MSL Team: The Tip of the Spear
Stacey Renee Benefiel, PharmD
Senior Director, MSL Operations
TriNet Pharma, United States

Building an MSL Team: The Tip of the Spear
Edmund J Cunningham, PharmD
Director, Speciality Care MSLs Medical Affairs
Eisai Inc., United States

Building an MSL Team: The Tip of the Spear
James Stephen Dodge, PharmD, MBA
Executive Director, US Medical Affairs Health System
Merck and Co., United States

Building an MSL Team: The Tip of the Spear
Bryan Vaughan, JD
Managing Partner
Trinet Pharma, United States

© 2014 DIA